| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/23/2006 | US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases |
| 03/23/2006 | US20060062779 Methods and compositions relating to mannuronic acid specific binding peptides |
| 03/23/2006 | US20060062778 Antibody buffering of a ligand in vivo |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062766 Remedy for cancer |
| 03/23/2006 | US20060062741 Elicits an immunological response and can even inhibit colonization by NTHi or M. catarrhalis and prevent otitis media and other respiratory diseases caused by NTHi or M. catarrhalis infection; drug delivery |
| 03/23/2006 | US20060062074 Method for intracellular modifications within living cells using pulsed electric fields |
| 03/23/2006 | CA2823429A1 Sialidase catalytic domain proteins |
| 03/23/2006 | CA2583199A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 03/23/2006 | CA2581017A1 Compositions monovalent for cd40l binding and methods of use |
| 03/23/2006 | CA2580717A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 03/23/2006 | CA2580362A1 Protective anti-glucan antibodies with preference for .beta.-1,3-glucans |
| 03/23/2006 | CA2580319A1 Vaccine |
| 03/23/2006 | CA2580261A1 Treatment of atherosclerosis |
| 03/23/2006 | CA2579900A1 Cancerous disease modifying antibodies |
| 03/23/2006 | CA2579527A1 Vaccines comprising plasmodium antigens |
| 03/23/2006 | CA2579141A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | CA2578050A1 Sialidase catalytic domain proteins |
| 03/23/2006 | CA2577989A1 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 03/23/2006 | CA2577133A1 Polypeptide variants with altered effector function |
| 03/23/2006 | CA2576940A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/22/2006 | EP1637614A2 Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus) |
| 03/22/2006 | EP1637602A1 Recombinant method for preparing of a complete malaria antigen gp190/msp1 |
| 03/22/2006 | EP1637601A2 Proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2006 | EP1637600A1 Chromosome 1 gene and gene products related to Alzheimer's disease |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637593A1 Process for the inactivation of enveloped viruses |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637173A2 Particle delivery |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637158A2 Capsular polysaccharide immunomodulator |
| 03/22/2006 | EP1637155A1 Method of mudulating memory effector T-cells using a CD2-binding agent, and compositions |
| 03/22/2006 | EP1637154A2 High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 03/22/2006 | EP1637147A1 Stable dust extract for allergy protection |
| 03/22/2006 | EP1637146A2 Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists |
| 03/22/2006 | EP1637037A2 Method for processing and preserving collagen-based tissues for transplantation |
| 03/22/2006 | EP1636561A2 Combinatorial protein library screening by periplasmic expression |
| 03/22/2006 | EP1636376A2 Differential gene expression in schizophrenia |
| 03/22/2006 | EP1636370A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 03/22/2006 | EP1636352A1 Improvements in virus production |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1636334A2 Recombinant anti-cd30 antibodies and uses thereof |
| 03/22/2006 | EP1636262A1 Interferon gamma-like protein |
| 03/22/2006 | EP1636261A2 Thrombopoietin proteins with improved properties |
| 03/22/2006 | EP1636259A2 Chemokine-binding protein thap1, methods and use thereof |
| 03/22/2006 | EP1636254A2 Replikin peptides and uses thereof |
| 03/22/2006 | EP1635871A2 Methods and compositions for treating rheumatoid arthritis |
| 03/22/2006 | EP1635870A2 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 03/22/2006 | EP1635869A1 Cancerous disease modifying antibodies |
| 03/22/2006 | EP1635867A1 Composition comprising iscom particles and live micro-organisms |
| 03/22/2006 | EP1635866A2 Modified antiviral peptides with increased activity and cell membrane affinity |
| 03/22/2006 | EP1635865A2 Immunogenic compositions for chlamydia trachomatis |
| 03/22/2006 | EP1635864A2 Immunogenic compositions comprising multiple gonococcal antigens |
| 03/22/2006 | EP1635863A2 Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes |
| 03/22/2006 | EP1635822A2 Methods and compositions for treating rheumatoid arthritis |
| 03/22/2006 | EP1635772A2 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 03/22/2006 | EP1635766A2 Lactoferrin as an adjuvant in cancer vaccines |
| 03/22/2006 | EP1635764A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 03/22/2006 | EP1404817B1 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1093818B1 Powdery preparation for mucosal administration containing polymeric medicine |
| 03/22/2006 | EP0951297B1 Detection of antigens via oligonucleotide antibody conjugates |
| 03/22/2006 | EP0948356B1 Agent for identifying and treating metastasizing tumours |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0832239B1 Camp factor of streptococcus uberis |
| 03/22/2006 | CN1751236A Transgenic mice expressing human CD20 |
| 03/22/2006 | CN1751064A Hsp60 from arthrobacter |
| 03/22/2006 | CN1750844A Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 03/22/2006 | CN1750843A Methods and compositions for inducing apoptosis in cancer cells |
| 03/22/2006 | CN1750840A Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 03/22/2006 | CN1750812A Virosome-like-particles |
| 03/22/2006 | CN1749397A Bi-recombinant active carrier vaccine of co-expression pig gyrate virus and foot and mouth disease virus |
| 03/22/2006 | CN1749395A Cloning and expression of Japan blood flukes SJCXSWL 02 gene and DNA vaccine |
| 03/22/2006 | CN1749394A Cloning and expression of Japan blood flukes HGPRT gene and DNA vaccine |
| 03/22/2006 | CN1748797A Polyepitope DNA vaccine of anti-simple herpes virus-2 infection and its preparing method |
| 03/22/2006 | CN1748793A Method for preparing cow foremilk immune globulin microcapsulation |
| 03/22/2006 | CN1748792A Application of semen momordicae extract containing triterpene saponin |
| 03/22/2006 | CN1748791A Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method |
| 03/22/2006 | CN1748712A Process for producing neogenetic bovine serum of bovine virus diarrhea virus anti-body negativity for producing swine fever vaccine |
| 03/22/2006 | CN1246697C Immune colloidal gold reagent for detecting Aibi-bacterium and preparation method thereof |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246038C Systemic delivery of oral vaccines of botulinus toxin |
| 03/22/2006 | CN1245989C Immune activator |
| 03/22/2006 | CN1245960C Non-oral preparation having three-layer structure |
| 03/22/2006 | CN1245957C Method for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 03/22/2006 | CN1245888C Anti-diarrhea yolk antibody feed additive for swine and injection formulation, and preparation method |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015035 RD114-based retroviral packaging cell line and related compositions and methods |
| 03/21/2006 | US7015024 Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 03/21/2006 | US7015016 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7014868 Hexameric complexes and their preparation |
| 03/21/2006 | US7014857 Anti-sepsis conjugate vaccine |
| 03/21/2006 | US7014856 for stimulating or enhancing production of an antibody which recognizes a ganglioside; comprises a ganglioside or oligosaccharide portion conjugated to an immunogenic protein with a carrier and/or vehicle; cancer treatment |
| 03/21/2006 | US7014855 inducing an immune response against a peptide component of an amyloid deposit; active administration of an immunogen or passive administration of an antibody or an active fragment or derivative of the antibody; Alzheimer's disease |
| 03/21/2006 | US7014854 Method for retarding or precluding Alzheimer's dementia |